Plans have increased patients’ prescription drug out-of-pocket costs by 36%, on average, since 2021

Outdated Cost-Effectiveness Analysis (CEA) Methodology Abroad Can Delay Access to Life-Saving Medicines for Patients in the U.S. and Globally and Disincentivize Future Innovation

Insurance Reform Needed to Cover Prescribed Medicines without High Out-of-Pocket Costs

“If a doctor prescribes a treatment and the insurer authorizes it, the copay should be affordable.”